glp-1 agonist and dpp-4 inhibitor What is the future of inhibitors? Medication like Sitagliptin, Linagliptin, Vildagliptin : 1. They will NOT disappear They still have a niche in: Elderly patients Frail patients CKD (especially Linagliptin – Role of DPP-4 Inhibitors in

All detailed data are presented in Table 2

Evidence shows that ROS generated from ETC and NOX can regulate several pathways that mediate autophagy induction (Li et al., 2011), and AMPK can be activated by AMPK kinase after H 2 O 2 treatment, which also results in autophagy induction (Choi et al., 2001)

Abstract Sulforaphane (SFN), an isothiocyanate derived from glucoraphanin in cruciferous vegetables, has evolved from a dietary antioxidant to a sophisticated multi-target agent in oncology

On day 1, mice underwent a single habituation session wherein animals were allowed to freely explore the arena for 5 min (both NOR and OLT)